-
Working Toward the End of Cancer Health Disparities
AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
-
Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
Diet and Cancer: Getting the Research Onto Your Plate
New studies each year purport to show associations between certain foods and cancer. Experts say to focus on the big picture.
by Anne Danahy
-
How Common Are Treatment Breakthroughs?
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
-
New Guidelines Recommend Exercise for Most Cancer Patients
People in treatment for early-stage cancer should try to get exercise, according to new recommendations.
by Sandra Gordon
-
E-Cigarettes Don’t Live Up to Promises
New studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
by Teresa Bergen
-
Forward Look
What’s NextNanoscopic biological computer kills cancer cells, spares healthy ones.
by Natalie Slivinksi
-
Forward Look
Drug Combinations for Advanced MelanomaResearchers find that when treating metastatic melanoma, timing is everything.
by Erin O'Donnell
-
Comorbidity: Treating the Whole Patient
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
-
From the Editor-in-Chief
RAS as an ‘Undruggable’ Drug TargetNew therapies are being developed to attack a previously untreatable cancer mutation.
by William G. Nelson, MD, PhD
Cancer Talk
Progress Against Cancer
New research fuels progress in cancer survival, prevention and side effect management.
Experts Urge Consideration Before Switching Cancer Care ProvidersPatients should consider the potential risks, and not just rewards, before changing providers.
by Kyle Bagenstose
Vaccines Spark Activity in Pancreatic CancerScientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
Navigating Out of Financial ToxicityPeople with cancer face an increased risk of financial hardship. Education and expert guidance can offer patients a lifeline.
by Thomas Celona